Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Emma Davé, Ralph Adams, Oliver Zaccheo, Bruce Carrington, Joanne E. Compson, Sarah Dugdale, Michael Airey, Sarah Malcolm, Hanna Hailu, Gavin Wild, Alison Turner, James Heads, Kaushik Sarkar, Andrew Ventom, Diane Marshall, Mark Jairaj, Tim Kopotsha, Louis Christodoulou, Miren Zamacona, Alastair D. Lawson, Sam Heywood & David P. Humphreys. (2016) Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin binding. mAbs 8:7, pages 1319-1335.
Read now
Read now
Focke Ziemssen, Bianka Sobolewska, Heidrun Deissler & Helmut Deissler. (2016) Safety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issues. Expert Opinion on Drug Safety 15:1, pages 75-87.
Read now
Read now
Articles from other publishers (2)
Fen Tang, Michelle E. LeBlanc, Weiwen Wang, Dan Liang, Ping Chen, Tsung-Han Chou, Hong Tian & Wei Li. (2019) Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety. Angiogenesis 22:3, pages 369-382.
Crossref
Crossref
Yusuke Tanetsugu, Tatsuaki Tagami, Takayuki Terukina, Takaya OgawaMasato OhtaTetsuya Ozeki. (2017) Development of a Sustainable Release System for a Ranibizumab Biosimilar Using Poly(lactic-<i>co</i>-glycolic acid) Biodegradable Polymer-Based Microparticles as a Platform. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 40:2, pages 145-150.
Crossref
Crossref